Having trouble accessing articles? Reset your cache.

Trius prices IPO

Trius Therapeutics Inc. (NASDAQ:TSRX) raised $50 million through the sale of 10

Read the full 122 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE